相关实验视频

Updated: Jan 11, 2026

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

母亲RSV疫苗接种的安全性和有效性:系统性审查和元分析

Ahmed Farag¹, Mohamed Karam Allah Elkholy², Amany Mahmoud Genidy³

¹Internal Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

Clinical and experimental vaccine research

|November 12, 2025

概括

母亲呼吸道同胞病毒 (RSV) 疫苗接种有效地保护新生儿免受RSV相关的下呼吸道疾病. 审查没有发现婴儿或母亲的安全问题,尽管需要更多的研究.

科学领域:

免疫学免疫学免疫学
儿科儿科儿科
公共卫生公共卫生

背景情况:

呼吸道同胞病毒 (RSV) 对新生儿构成重大健康风险.
孕产妇疫苗接种是一种在婴儿最初易受伤害的几个月内为婴儿提供被动免疫力的策略.
目前在婴儿中对RSV的预防措施有限.

研究的目的:

系统地审查和评估母体RSV疫苗的有效性和安全性.
综合来自随机对照试验 (RCT) 关于母亲RSV疫苗接种结果的证据.
评估母亲RSV疫苗接种对婴儿呼吸系统疾病和安全参数的影响.

主要方法:

按照PRISMA指南进行系统审查和元分析.
在主要数据库中进行文献搜索:MEDLINE (PubMed),Scopus,科学网和Cochrane.
包括评估母体RSV疫苗安全性和有效性的RCT.

主要成果:

母亲接种RSV疫苗显著减少了RSV相关的下呼吸道感染 (LRTI),严重的LRTI和婴儿住院.
在关键的胎儿和新生儿安全结果中没有观察到统计学意义上的差异,包括先天性异常和婴儿死亡.
在母体疫苗接种和对照组之间,没有发现早产率的显著差异.

结论:

母亲RSV疫苗接种是保护婴儿免受RSV相关呼吸道疾病的有效策略.
目前的证据表明,母体RSV疫苗接种的安全性概况有利,没有发现重大问题.
建议进一步进行高质量的RCT,以巩固这些发现并解决剩余的证据缺口.

关键词:

婴儿婴儿婴儿婴儿婴儿婴儿呼吸系统同胞性病毒呼吸道感染呼吸道感染疫苗接种疫苗接种

更多相关视频

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

相关概念视频

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

Vaccinations

Vaccinations

Teratogenicity

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...